Market Tracker

06/27 3:32am ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

3.17
Delayed Data
As of Jun 24
 +0.07 / +2.26%
Today’s Change
2.28
Today|||52-Week Range
11.65
-31.68%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close3.10
Today’s open2.90
Day’s range2.86 - 3.24
Volume1,348,826
Average volume (3 months)541,935
Market cap$126.1M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+27.21%
Earnings growth (this year)-26.05%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales51.91
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc-0.20-7.35%
LPCNLipocine Inc-0.31-4.31%
ARQLArQule Inc-0.01-0.52%
MSLIMerus Labs Internati...-0.06-4.85%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$3.2M
Annual profit (last year)-$35.2M
Net profit margin-1,105.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Paul F. Truex
President &
Chief Operating Officer
John Craig Thompson
Corporate headquarters
Hayward, California

Forecasts